SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Stifel Maintains Hold on Aimmune Therapeutics, Lowers Price Target to $20

Stifel maintains Aimmune Therapeutics (NASDAQ:AIMT) with a Hold and lowers the price target from $32 to $20.

Benzinga · 05/12/2020 13:24

Stifel maintains Aimmune Therapeutics (NASDAQ:AIMT) with a Hold and lowers the price target from $32 to $20.